Link, Hartmut http://orcid.org/0000-0002-9659-0265
Illerhaus, G.
Martens, U. M.
Salar, A.
Depenbusch, R.
Köhler, A.
Engelhardt, M.
Mahlmann, S.
Zaiss, M.
Lammerich, A.
Bias, P.
Buchner, A.
Article History
Received: 30 April 2020
Accepted: 20 August 2020
First Online: 17 September 2020
Compliance with ethical standards
:
: HL declares to have received personal fees from Teva, Amgen, Chugai, Hexal-Sandoz-Novartis, Mundipharma, Accord Healthcare, and G1 Therapeutics; AK has received a grant from Amgen; AS has received grants from Roche and Gilead and personal fees from Roche, Gilead, Celgene, and Janssen; MZ has received personal fees from Novartis, Hexal, Pfizer, Roche; GI, ME, RD, SM, and UM have no disclosures to declare; PB, AB, and AL are employees of Teva and hold stock options in the company<b>.</b>